A randomized trial of rectal indomethacin and sublingual nitrates to prevent post-ERCP pancreatitis

American Journal of Gastroenterology

Volumn 109, Issue 6, 2014, Pages 903-909

  Sotoudehmanesh, Rasoul ^a   Eloubeidi, Mohamad Ali ^b   Asgari, Ali Ali ^a   Farsinejad, Maryam ^a   Khatibian, Morteza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLASE; INDOMETACIN; ISOSORBIDE DINITRATE; PLACEBO;

ABDOMINAL PAIN; ACUTE PANCREATITIS; ADULT; AGED; AMYLASE BLOOD LEVEL; ARTICLE; BLEEDING; CHEMOPROPHYLAXIS; CHOLANGITIS; CLINICAL EVALUATION; COMBINATION CHEMOTHERAPY; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MONOTHERAPY; PERFORATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SUPPOSITORY; TREATMENT OUTCOME;

CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; HUMANS; INDOMETHACIN; NITRATES; PANCREATITIS;

EID: 84902081486     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2014.9     Document Type: Article

References (34)

1. Rabenstein T, Hahn EG. Post-ERCP pancreatitis: New momentum. Endoscopy 2002;34;325-9. (Pubitemid 34279524
2. Vandervoort J, Soetikno RM, Th am TC, et al. Risk factors for complications aft er performance of ERCP. Gastrointest Endosc 2002;56;652-6
3. Whitcomb DC. Acute pancreatitis: Molecular biology update. J Gastrointest Surg 2003;7;940-2. (Pubitemid 37524059
4. Gross V, Leser HG, Heinisch A, et al. Infl ammatory mediators and cytokines: New aspects of the pathophysiology and assessment of severity of acute pancreatitis?. Hepatogastroenterology 1993;40;522-30
5. MäkeläA, Kuusi T, Schr ö der T. Inhibition of serum phospholipase-A2 in acute pancreatitis by pharmacological agents in vitro. Scand J Clin Lab Invest 1997;57;401-7
6. Dai HF, Wang XW, Zhao K. Role of nonsteroidal anti-infl ammatory drugs in the prevention of post-ERCP pancreatitis: A meta-Analysis. Hepatobiliary Pancreat Dis Int 2009;8;11-6
7. Elmunzer BJ, Waljee AK, Elta GH, et al. A meta-Analysis of rectal NSAIDs in the prevention of post-ERCP pancreatitis. Gut 2008;57;1262-7
8. Zheng MH, Xia HH, Chen YP. Rectal administration of NSAIDs in the prevention of post-ERCP pancreatitis: A complementary meta-Analysis. Gut 2008;57;1632-3
9. Elmunzer BJ, Scheiman JM, Lehman GA, et al. A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis. N Engl J Med 2012;366;1414-22
10. Dumonceau JM, Andriulli A, Deviere J, et al. European Society of Gastrointestinal Endoscopy (ESGE) Guideline: Prophylaxis of post-ERCP pancreatitis. Endoscopy 2010;42;503-15
11. Bang UC, N ø jgaard C, Andersen PK, et al. Meta-Analysis: Nitroglycerin for prevention of post-ERCP pancreatitis. Aliment Pharmacol Ther 2009;29;1078-85
12. Shao LM, Chen QY, Chen MY, et al. Nitroglycerin in the prevention of post-ERCP pancreatitis: A meta-Analysis. Dig Dis Sci 2010;55;1-7
13. Chen B, Fan T, Wang CH. A meta-Analysis for the Effect of prophylactic GTN on the incidence of post-ERCP pancreatitis and on the successful rate of cannulation of bile ducts. BMC Gastroenterol 2010;10;85
14. Cotton PB, Lehman G, Vennes J, et al. Endoscopic sphincterotomy complications and their management: An attempt at consensus. Gastrointest Endosc 1991;37;383-93
15. Hogan WJ, Geenen JE. Biliary dyskinesia. Endoscopy 1988;20 (Suppl 1);179-83
16. Jennison C, Turnbull BW. Group Sequential Methods with Applications to Clinical Trials. Chapman and Hall: New York, NY, USA, 2000
17. Bhatia V, Ahuja V, Acharya SK, et al. A randomized controlled trial of valdecoxib and glyceryl trinitrate for the prevention of post-ERCP pancreatitis. J Clin Gastroenterol 2011;45;170-6
18. Talwar A, Dare C, Pain J. Does topical GTN on the sphincter of Oddi facilitate ERCP?. A double-blind randomized control trial. Surg Endosc 2005;19;902-4. (Pubitemid 41279577
19. Gorelick A, Barnett J, Chey W, et al. Botulinum toxin injection aft er biliary sphincterotomy. Endoscopy 2004;36;170-3. (Pubitemid 38180604
20. Matsushita M, Takakuwa H, Shimeno N, et al. Epinephrine sprayed on the papilla for prevention of post-ERCP pancreatitis. J Gastroenterol 2009;44;71-5
21. Schwartz JJ, Lew RJ, Ahmad NA, et al. The Effect of lidocaine sprayed on the major duodenal papilla on the frequency of post-ERCP pancreatitis. Gastrointest Endosc 2004;59;179-84. (Pubitemid 38199209
22. Prat F, Amaris J, Ducot B, et al. Nifedipine for prevention of post-ERCP pancreatitis: A prospective, double-blind randomized study. Gastrointest Endosc 2002;56;202-8
23. Sand J, Nordback I. Prospective randomized trial of the Effect of nifedipine on pancreatic irritation aft er endoscopic retrograde cholangiopancreatography. Digestion 1993;54;105-11. (Pubitemid 23160626
24. Wehrmann T, Schmitt T, Stergiou N, et al. Topical application of nitrates onto the papilla of Vater: Manometric and clinical results. Endoscopy 2001;33;323-8. (Pubitemid 32586422
25. Devière J, Le Moine O, Van Laethem JL, et al. Interleukin 10 reduces the incidence of pancreatitis aft er therapeutic endoscopic retrograde cholangiopancreatography Gastroenterology 2001;120;498-505
26. Kylänpää ML, Repo H, Puolakkainen PA. Infl ammation and immunosuppression in severe acute pancreatitis. World J Gastroenterol 2010;16;2867-72
27. Sotoudehmanesh R, Khatibian M, Kolahdoozan S, et al. Indomethacin may reduce the incidence and severity of acute pancreatitis aft er ERCP. Am J Gastroenterol 2007;102;978-83. (Pubitemid 46698240
28. Dumonceau JM, Rigaux J, Kahaleh M, et al. Prophylaxis of post-ERCP pancreatitis: A practice survey. Gastrointest Endosc 2010;71;934-9
29. Khoshbaten M, Khorram H, Madad L, et al. Role of diclofenac in reducing post-endoscopic retrograde cholangiopancreatography pancreatitis. J Gastroenterol Hepatol 2008;23;e11-6
30. Nelson DB, Freeman ML. Major hemorrhage from endoscopic sphincterotomy: Risk factor analysis. J Clin Gastroenterol 1994;19;283-7. (Pubitemid 24371048
31. MoretóM, Zaballa M, Casado I, et al. Transdermal glyceryl trinitrate for prevention of post-ERCP pancreatitis: A randomized double-blind trial. Gastrointest Endosc 2003;57;1-7. (Pubitemid 36236791
32. Beauchant M, Ingrand P, Favriel JM, et al. Intravenous nitroglycerin for prevention of pancreatitis aft er therapeutic endoscopic retrograde cholangiography: A randomized, double-blind, placebo-controlled multicenter trial. Endoscopy 2008;40;631-6
33. Ismail S, Kylänpää L, Mustonen H, et al. Risk factors for complications of ERCP in primary sclerosing cholangitis. Endoscopy 2012;44;1133-8
34. Freeman ML, DiSario JA, Nelson DB, et al. Risk factors for post-ERCP pancreatitis: A prospective, multicenter study. Gastrointest Endosc 2001;54;425-34. (Pubitemid 33661145